A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome
Clinical trial NCT02400463 · COMPLETED
Trial details
- NCT number
- NCT02400463
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-05
- Primary completion
- 2019-10-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.